POST Online Media Lite Edition



 

Teva says CFO Michael McClellan will step down

Christian Fernsby |
Jerusalem, Israel - Teva Pharmaceutical Industries announced that Michael McClellan, executive vice president and chief financial officer, has decided to step down from his role as CFO due to personal reasons.


Mr. McClellan was appointed Teva's CFO in November 2017 after serving as Senior Vice President and Interim Group Chief Financial Officer from July 2017.

 LATEST MOVES FROM Israel 

Cellcom Israel chairman Ami Erel to step down
Nano Dimension appoints Miri Naveh to board
MaxQ AI announces Tom Neufelder as chief technology officer
SodaStream appoints Bryan Welsh as general manager of SodaStream USA
Protalix BioTherapeutic appoints David Granot to board

What to read next

b
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Camp
b
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Camp
b
Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August